Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children's Research Hospital. Many people with ...

“We now have emerging data to at least evaluate the efficacy of gene therapy in patients with a risk of or history of stroke,” Sharma said. “Until now, we only had one option that had a long-term ...

June 27, 2025) Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports ...

DelveInsight's Frontotemporal Dementia Market Insights report includes a comprehensive understanding of current treatment ...

TECH teams up with USP to boost mAb and gene therapy testing, aiming to simplify analytics and enhance product quality.

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...